Sonja J. Gill

488 total citations
5 papers, 83 citations indexed

About

Sonja J. Gill is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sonja J. Gill has authored 5 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Sonja J. Gill's work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and Cancer-related gene regulation (1 paper). Sonja J. Gill is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and Cancer-related gene regulation (1 paper). Sonja J. Gill collaborates with scholars based in United Kingdom, United States and Poland. Sonja J. Gill's co-authors include Syd Barthorpe, Tatiana Mironenko, Cyril H. Benes, Mathew J. Garnett, Laura Richardson, Michael R. Stratton, Jon Travers, Stephen P. Jackson, Ultan McDermott and Jacqueline H. L. Fok and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Sonja J. Gill

4 papers receiving 82 citations

Peers

Sonja J. Gill

ONCOL

MB

PRM

EEE

GENET

François‐Xavier Gros France

Sophie E. Willis United Kingdom

Adam J. Mansfield United States

Patrick Schummer Germany

O. Becquart France

Enyu Dai United States

Erin E. Tapper United States

Yitzhar Goretsky United States

Amrita Sule United States

Alexander Desuki Germany

François‐Xavier Gros France

Sonja J. Gill

48 ×0.8

ONCOL

29 ×0.5

MB

8 ×0.5

PRM

9 ×0.7

EEE

7 ×0.9

GENET

Citations per year, relative to Sonja J. Gill Sonja J. Gill (= 1×) peers François‐Xavier Gros

Countries citing papers authored by Sonja J. Gill

Since Specialization

Citations

This map shows the geographic impact of Sonja J. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja J. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja J. Gill more than expected).

Fields of papers citing papers by Sonja J. Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja J. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja J. Gill. The network helps show where Sonja J. Gill may publish in the future.

Co-authorship network of co-authors of Sonja J. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja J. Gill. A scholar is included among the top collaborators of Sonja J. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja J. Gill. Sonja J. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Gill, Sonja J., et al.. (2023). Optic Perineuritis as the Initial Presentation of Syphilis in a Patient on Biologics. The Journal of Rheumatology. 50(11). 1515–1515.

2.

Lynch, James T., Shaun Moore, Iván del Barco Barrantes, et al.. (2023). Abstract 6272: AZ-PRMT5i-1: A potent MTAP-selective PRMT5 inhibitor with pharmacodynamic and monotherapy anti-tumor activity in MTAP-deleted tumours. Cancer Research. 83(7_Supplement). 6272–6272. 2 indexed citations

3.

Gill, Sonja J., Paul W.G. Wijnhoven, Jacqueline H. L. Fok, et al.. (2021). Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development. Molecular Cancer Therapeutics. 20(9). 1614–1626. 17 indexed citations

4.

Gill, Sonja J., Ruth S. MacDonald, Carmen Pin, et al.. (2021). Abstract 1374: The novel PARP1-selective inhibitor AZD5305 has reduced hematological toxicity when compared to PARP1/2 inhibitors in pre-clinical models. Cancer Research. 81(13_Supplement). 1374–1374. 2 indexed citations

5.

Gill, Sonja J., Jon Travers, Syd Barthorpe, et al.. (2015). Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing’s Sarcoma. PLoS ONE. 10(10). e0140988–e0140988. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact